AGP Executive Report
Last update: 10 hours agoPublic Safety Crackdown: LAPD is stepping up DUI enforcement with checkpoints across Labor Day weekend, urging drivers to plan for sober rides and avoid distractions. Cannabis Health Watch: A CDC update flags 199,565 emergency visits tied to cannabis hyperemesis syndrome from Jan. 2023 to May 2026, with a jump after CHS got a dedicated diagnostic code in Oct. 2025. CBD Research Roundup: A new review finds cannabidiol and cannabis may offer “therapeutic promise” for restless leg syndrome, but calls for stronger randomized trials. Pregnancy & Cannabis Science: A Nature placenta atlas links specific uterine/placental cell patterns to higher pregnancy complication risk and points to increased risk signals tied to cannabis use. Industry & Markets: Curaleaf attacks Aurora’s strategy in a shareholder dispute, arguing Aurora’s “debt-free” pitch ignores dilution and cash burn. Hemp Policy: North Carolina lawmakers face a November decision on regulating intoxicating hemp products, while the U.S. House delays a national ban on intoxicating hemp THC products to Dec. 11. Verification & Counterfeits: Muha Meds highlights cannabis verification as fake vape packaging gets more convincing, pushing authentication before purchase. Cybercrime Risk: The FBI is investigating a dark-web service selling massive driving licence scans, including medical IDs tied to marijuana access.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
